Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torben Palshof

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
European Journal of Nuclear Medicine and Molecular Imaging|June 16, 2012
Monitoring renal function during chemotherapyLouise B Hartlev, Charlotte R Boeje, Henrik Bluhme, et al.
Ugeskrift for Laeger|November 7, 2008
[Monitoring renal function in patients treated with cytostatics]Louise Brøndt Hartlev, Charlotte Bøje Rotbøl, Henrik Bluhme, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 25, 2014
Nationwide quality improvement in lung cancer care: the role of the Danish Lung Cancer Group and RegistryErik Jakobsen, Anders Green, Kell Oesterlind, et al.
Acta Oncologica (Stockholm, Sweden)|November 23, 2017
Two years of tamoxifen or no adjuvant systemic therapy for patients with high-risk breast cancer: long-term follow-up of the Copenhagen breast cancer trialMaj-Britt Jensen, Jens Fabricius Krarup, Torben Palshof, et al.
Lung Cancer (Amsterdam, Netherlands)|November 27, 2007
Topotecan and cisplatin in combination with concurrent twice-daily chemoradiation in limited disease small cell lung cancer-a Danish Oncological Lung Cancer Group (DOLG) phase II trialMorten Sorensen, Ulrik Lassen, Torben Palshof, et al.
Ugeskrift for Laeger|February 13, 2002
[Palliative medicine education]Lise Pedersen, Anders Bonde Jensen, Bent Enig, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
The value of HRCT and Tc-depreotide in the evaluation of pulmonary lesionsKarin Rasmussen, Hans H Madsen, Finn Rasmussen, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
European Journal of Nuclear Medicine and Molecular Imaging|June 16, 2012
Monitoring renal function during chemotherapyLouise B Hartlev, Charlotte R Boeje, Henrik Bluhme, et al.
Ugeskrift for Laeger|November 7, 2008
[Monitoring renal function in patients treated with cytostatics]Louise Brøndt Hartlev, Charlotte Bøje Rotbøl, Henrik Bluhme, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 25, 2014
Nationwide quality improvement in lung cancer care: the role of the Danish Lung Cancer Group and RegistryErik Jakobsen, Anders Green, Kell Oesterlind, et al.
Acta Oncologica (Stockholm, Sweden)|November 23, 2017
Two years of tamoxifen or no adjuvant systemic therapy for patients with high-risk breast cancer: long-term follow-up of the Copenhagen breast cancer trialMaj-Britt Jensen, Jens Fabricius Krarup, Torben Palshof, et al.
Lung Cancer (Amsterdam, Netherlands)|November 27, 2007
Topotecan and cisplatin in combination with concurrent twice-daily chemoradiation in limited disease small cell lung cancer-a Danish Oncological Lung Cancer Group (DOLG) phase II trialMorten Sorensen, Ulrik Lassen, Torben Palshof, et al.
Ugeskrift for Laeger|February 13, 2002
[Palliative medicine education]Lise Pedersen, Anders Bonde Jensen, Bent Enig, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
The value of HRCT and Tc-depreotide in the evaluation of pulmonary lesionsKarin Rasmussen, Hans H Madsen, Finn Rasmussen, et al.
Pageof 2